"In Southwest Michigan, Ascension Borgess Hospital is a full-service hospital with 24/7 emergency care and surgical specialists. Our care teams deliver personalized care for serious and life-threatening injuries and illnesses and your everyday health needs, including labor and delivery. We listen to quickly understand your health needs to deliver care that is right for you. We offer many specialty care services for diabetes, heart and vascular disease, lung and sleep disorders, mental health conditions, obesity, orthopedic joint care and women’s health. A wide range of outpatient services are available, including diagnostic imaging, lab tests, respiratory therapy, and rehabilitation therapy services all on one campus."

During the past decade, Borgess Medical Center conducted 139 clinical trials. In the 10-year time frame, 139 clinical trials started and 195 clinical trials were completed, i.e. on average, 140.3% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 82 clinical trials were completed. i.e. 143.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Borgess Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 133 trials, followed by "SWOG Cancer Research Network" with 59 trials sponsored, "Alliance for Clinical Trials in Oncology" with 44 trials sponsored, "Eastern Cooperative Oncology Group" with 41 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 41 trials sponsored. Other sponsors include 99 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Borgess Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 247 trials as a collaborator, "NRG Oncology" with 42 trials as a collaborator, "Cancer and Leukemia Group B" with 15 trials as a collaborator, "NCIC Clinical Trials Group" with 13 trials as a collaborator and "SWOG Cancer Research Network" with 13 trials as a collaborator. Other collaborators include 93 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "Borgess Medical Center" are "Breast Cancer" (22 trials), "Lung Cancer" (18 trials), "Lymphoma" (18 trials), "Colorectal Cancer" (13 trials) and "Leukemia" (13 trials). Many other conditions were trialed in "Borgess Medical Center" in a lesser frequency.

Most popular intervention types in "Borgess Medical Center" are "Drug" (320 trials), "Other" (196 trials), "Biological" (147 trials), "Procedure" (90 trials) and "Radiation" (70 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (100 trials), "Quality-of-Life Assessment" (63 trials), "Paclitaxel" (44 trials), "Questionnaire Administration" (44 trials) and "Bevacizumab" (33 trials). Other intervention names were less common.

The vast majority of trials in "Borgess Medical Center" are 314 trials for "All" genders, 88 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Borgess Medical Center". undefined are not yet recruiting, 59 are recruiting, 116 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 193 completed trials in Borgess Medical Center, 4 suspended trials, and 30 terminated clinical trials to date.

Out of the total trials that were conducted in Borgess Medical Center, 9 "Phase 1" clinical trials were conducted, 184 "Phase 2" clinical trials and 188 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 17 trials that are defined as “Not Applicable".